http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017063542-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4711b7defc1422cdb7f86d2c95657bf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2016-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20887a9dce1d883ae110596610a7465c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8a9b458aef9e24eb4264b88678ed6c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de522b076ff5616c92fe9d3d69f5d491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6474a281f498aa4d882ce33cd51f2a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d8daa2ae7b3e3ed2b58feedb0d9ec56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a56c545245259ea88d8b6877cd9cb80c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc34363caa044168d2508ec5af2807ca
publicationDate 2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017063542-A1
titleOfInvention Stabilized a7r polypeptides, and use thereof in constructing tumor targeted therapeutic drug delivery system
abstract Provided are a retro-inverso polypeptides, DA7R, and a head-to-tail cyclized polypeptides with an amide bond, cA7R, having a high binding activity with vascular endothelial growth factor receptor-2 and neuropilin-1, and said polypeptides have an anti-tumor effect. Also provided are a composite of the polypeptides with a fluorescein, a drug, or a polymer carrier material, a preparation method thereof, and a use thereof in tumor imaging and targeted therapeutic drug delivery system construction.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112279887-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113384682-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113384682-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113337468-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113372412-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110386962-A
priorityDate 2015-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004009131-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65070

Total number of triples: 37.